Objective To determine the content of total flavonoids and luteolin from Pteris multifida Poir. Methods The content of total flavonoids was determined by gradient elution of macroporous resin D101 and ultraviolet spectrophotometry. The content of luteolin was determined by HPLC. The analysis was performed on a RP-C18 column(4.6 mm×250 mm, 5 μm) with aceconitrile-0.2% phosphoric acid (35:65) as the mobile phase at a flow rate of 1.0 ml/min, and 30 ℃ temperature. Results The detection of wave length was set at 349 nm. The content of luteolin was 0.015%, 0.019%, 0.016%, and the content of total flavonoids was 0.015%, 0.019%, 0.016%, respectively. Conclusions The method is suitable for the determination of flavonoids componets from Pteris multifida Poir.

Objective To establish an HPLC method for simultaneous determination of Isoquercitrin and astragalin in Moringa oleifera leaves prescription. Methods By using HPLC method with Cosmosil-C18 column (4.6 mm × 250 mm, 5 μm) and the column temperature was 40 degrees Celsius, the mobile phase contains a 0.1％phosphoric acid in water(A) and acetonitrile(B), the detection wavelength was set at 350nm by UV detector and the flow rate was 1.3 ml/min. Results The Isoquercitrin and astragalin was better separated in 30 minutes, and Isoquercitrin had a good linear correlation at the range of 0.24-4.73 μg, while astragalin was 0.11-2.19 μg, the average spiked recoveries of isoquercetin and astragalin were 99.09％ (RSD=0.60％) and 99.08％ (RSD=1.37％), respectively. Conclusions The proposed method is simple,accurate,and repeatable and can be used for quality control as well as a powerful tool to evaluate the processing of Moringa oleifera leaves. It can provide the reference basis and data support for the determination of content of Moringa oleifera health products.

Objective:To develop the Fear of Disease Progression Scale for Patients with Acute Myocardial Infarction, and test its reliability and validity.Methods:The first draft of the scale was formed through literature review, qualitative interviews, and Delphi expert consultations. From March to July 2020, convenience sampling method was adopted to conduct a formal survey of 200 patients with acute myocardial infarction admitted to the Department of Cardiology in three ClassⅢ Grade A hospitals in Jiangsu Province. The formal scale was formed through the project analysis and exploratory factor analysis, and its reliability and validity were determined. 200 questionnaires were distributed, and 178 valid questionnaires were recovered, with a valid recovery rate of 89.00%.Results:The final scale contained 17 items, and exploratory factor analysis extracted 3 common factors, and the cumulative contribution rate of variance was 62.671%. The item-level content validity index ( I- CVI) was from 0.83 to 1.00, the scale-level content validity index ( S- CVI) was 0.82, and the average S- CVI was 0.97. The Cronbach's α coefficient of the total scale was 0.892, the half-reliability was 0.764, and the test-retest reliability was 0.964. Conclusions:The developed Fear of Disease Progression Scale for Patients with Acute Myocardial Infarction has good reliability and validity, which can be used to assess the current status of fear of disease progression in patients with acute myocardial infarction.